Literature DB >> 2833622

DNA rearrangements in organ-specific variants of polyomavirus JC strain GS.

G Loeber1, K Dörries.   

Abstract

Variants of JC virus (JCV) strain GS were isolated directly from the central nervous system (variant GS/B) and the kidney (variant GS/K) of a patient with progressive multifocal leukoencephalopathy and were cloned and sequenced. The genomes of the isolates were shown to be nearly identical in the nucleotide sequences of their protein-coding regions, suggesting that both had originated from a single infecting JCV genome. In contrast, the arrangement of the putative elements of transcriptional control revealed considerable differences. The tandemly repeated elements found twice within the enhancer region of JCV GS/B variant were not present in the GS/K variant. The missing elements were replaced by DNA segments containing simian virus 40 and adenovirus E1A core enhancer elements. These differences in the organ-specific GS variants suggest that rearrangements within elements of transcriptional control might be involved in altering the virus-cell interaction in the course of a JCV infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2833622      PMCID: PMC253214          DOI: 10.1128/JVI.62.5.1730-1735.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  The genome of human papovavirus BKV.

Authors:  I Seif; G Khoury; R Dhar
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

2.  In vitro packaging of lambda and cosmid DNA.

Authors:  B Hohn
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

3.  Structure and function of the transcriptional control region of nonpassaged BK virus.

Authors:  R Rubinstein; N Pare; E H Harley
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

4.  Detection of polyoma virus DNA in PML-brain tissue by (in situ) hybridization.

Authors:  K Dörries; R T Johnson; V ter Meulen
Journal:  J Gen Virol       Date:  1979-01       Impact factor: 3.891

5.  Adenine arabinoside in the treatment of progressive multifocal leukoencephalopathy: use of virus-containing cells in the urine to assess response to therapy.

Authors:  K H Rand; K P Johnson; L J Rubinstein; J S Wolinsky; J B Penney; D L Walker; B L Padgett; T C Merigan
Journal:  Ann Neurol       Date:  1977-05       Impact factor: 10.422

6.  Screening lambdagt recombinant clones by hybridization to single plaques in situ.

Authors:  W D Benton; R W Davis
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

7.  Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy.

Authors:  B L Padgett; D L Walker; G M ZuRhein; R J Eckroade; B H Dessel
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321

8.  Analysis of the early regulatory region of the human papovavirus BK.

Authors:  K L Deyerle; J A Cassill; S Subramani
Journal:  Virology       Date:  1987-05       Impact factor: 3.616

9.  BK virus DNA: complete nucleotide sequence of a human tumor virus.

Authors:  R C Yang; R Wu
Journal:  Science       Date:  1979-10-26       Impact factor: 47.728

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  55 in total

1.  Typing of urinary JC virus DNA offers a novel means of tracing human migrations.

Authors:  C Sugimoto; T Kitamura; J Guo; M N Al-Ahdal; S N Shchelkunov; B Otova; P Ondrejka; J Y Chollet; S El-Safi; M Ettayebi; G Grésenguet; T Kocagöz; S Chaiyarasamee; K Z Thant; S Thein; K Moe; N Kobayashi; F Taguchi; Y Yogo
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

2.  BK virus and JC virus shed during pregnancy have predominantly archetypal regulatory regions.

Authors:  R B Markowitz; B A Eaton; M F Kubik; D Latorra; J A McGregor; W S Dynan
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Enhancer/promoter activities of regulatory regions of representative JC virus isolates.

Authors:  J D Martin; P Li
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

4.  Recurring theme of changes in the transcriptional control region of BK virus during adaptation to cell culture.

Authors:  R Rubinstein; B C Schoonakker; E H Harley
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

5.  Sequence rearrangement in JC virus DNAs molecularly cloned from immunosuppressed renal transplant patients.

Authors:  Y Yogo; T Kitamura; C Sugimoto; K Hara; T Iida; F Taguchi; A Tajima; K Kawabe; Y Aso
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

6.  Direct isolation and characterization of JC virus from urine samples of renal and bone marrow transplant patients.

Authors:  C Myers; R J Frisque; R R Arthur
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

Review 7.  Co-existing disorders in ADHD -- implications for diagnosis and intervention.

Authors:  Christopher Gillberg; I Carina Gillberg; Peder Rasmussen; Björn Kadesjö; Henrik Söderström; Mania Råstam; Mato Johnson; Aribert Rothenberger; Lena Niklasson
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

8.  Archetype JC virus efficiently replicates in COS-7 cells, simian cells constitutively expressing simian virus 40 T antigen.

Authors:  K Hara; C Sugimoto; T Kitamura; N Aoki; F Taguchi; Y Yogo
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Propagation of archetype and nonarchetype JC virus variants in human fetal brain cultures: demonstration of interference activity by archetype JC virus.

Authors:  Frank J O'Neill; John E Greenlee; Kristina Dörries; Susan A Clawson; Helen Carney
Journal:  J Neurovirol       Date:  2003-10       Impact factor: 2.643

10.  Asian genotypes of JC virus in Japanese-Americans suggest familial transmission.

Authors:  Makoto Suzuki; Huai-Ying Zheng; Tomokazu Takasaka; Chie Sugimoto; Tadaichi Kitamura; Ernest Beutler; Yoshiaki Yogo
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.